Today, the Non-Executive of OrganiGram Holdings (OGI), Stephen A Smith, bought shares of OGI for $7,000.
Following this transaction Stephen A Smith’s holding in the company was increased by 63% to a total of $13.7K. This is Smith’s first transaction since reporting a Buy transaction on TSE:MAV back in November 2019
See today’s analyst top recommended stocks >>
The company has a one-year high of $6.06 and a one-year low of $1.09.
Based on 9 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $2.49, reflecting a -46.2% downside. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy OGI with a $3.00 price target. Five different firms, including Raymond James and Alliance Global Partners, currently also have a Buy rating on the stock.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Read More on OGI:
